ABSTRACT
M
iddle ear cholesteatomas are benign but locally aggressive nonneoplastic lesions composed of a keratinizing stratified squamous epithelial matrix, an inflammatory perimatrix, and desquamated keratin content. 1 Pathophysiologically, cholesteatomas are divided into congenital (epithelium trapped within the middle ear during fetal development) and acquired. Acquired cholesteatomas are further divided into primary (arising from a tympanic membrane retraction) and secondary (epithelium reaching the middle ear through a tympanic perforation, fracture, or iatrogenic procedure). 2, 3 Cholesteatomas progressively erode the bony structures surrounding the middle ear (ossicles, facial nerve canal, bony labyrinth, and skull base), predisposing to a wide range of complications, including potentially severe infections such as meningitis and intracranial abscesses. 4 Surgery is the only known curative treatment and should be performed early because less destruction allows more conservative and hearingpreserving procedures with a reduced risk of complications. Tympanic retraction pockets are invaginations of the tympanic membrane into the middle ear cleft caused by Eustachian tube dysfunction, which interferes with proper middle ear ventilation. 5 The diagnosis of a "dangerous" or high-risk retraction pocket is proposed when the bottom of the pocket becomes hidden to the otomicroscope and/or starts retaining skin, because this may lead to primary acquired cholesteatoma. 1 Given that there is a continuum from tympanic retraction pockets to small cholesteatomas, the distinction between retraction pockets that have already developed a cholesteatoma and those that have not remains a problem in otologic surgery because conventional clinical and radiologic methods are often insufficient. In addition, dangerous retraction pockets and small cholesteatomas share similar clinical signs and symptoms, and it is often impossible to differentiate them via otomicroscopy. A substantial number of such patients undergo surgical procedures such as mastoidectomies or atticotomies, but only a subset actually have cholesteatomas.
CT is the most widely used imaging technique for the detection of a middle ear mass and assessing tympanomastoid anatomy and the extent of bone erosion. 6 However, it is nonspecific for cholesteatoma and relies on indirect signs for its diagnosis. 7, 8 More recently, MR imaging techniques have been used to differentiate cholesteatoma from other middle ear masses, especially T1-weighted delayed postcontrast imaging and DWI. 9, 10 DWI techniques are based on the restriction of movement of water molecules, such as that caused by keratin-filled cholesteatomas, producing a hyperintense signal. 11 Conventional EPI has been displaced by non-EPI techniques when the temporal bone is the focus, because these sequences have fewer artifacts and thinner sections, allowing the detection of cholesteatomas as small as 2 mm. 12 Several studies of non-echo-planar (EP) DWI have provided excellent sensitivity and specificity for the detection of cholesteatomas. Currently, MR imaging is suggested when the diagnosis of cholesteatoma cannot be established by other means, often in the setting of congenital and residual/recurrent disease. 10 The purpose of this study was to evaluate the sensitivity and specificity of non-EP DWI for the detection of cholesteatomas in skin-retaining and/or otomicroscopically inaccessible tympanic retraction pockets.
MATERIALS AND METHODS

Research Design
A prospective study was conducted at the Department of Otorhinolaryngology in our institution. HASTE non-EP DWI MR imaging was performed within 2 months before surgery, in addition to standard examinations, including audiometry and temporal bone CT. HASTE images were blindly interpreted by an experienced neuroradiologist, and radiologic diagnosis of cholesteatoma was considered when a marked hyperintensity in comparison with brain tissue was noted on DWI. After all patients had been recruited, a second neuroradiologist revised all HASTE images to evaluate the interobserver agreement of the test.
Patients with tympanic membrane retraction pockets in which a cholesteatoma could not be ruled out or confirmed were included. Exclusion criteria included previously operated ears, clinically evident cholesteatomas, contraindications for MR imaging, and refusal by the patient. Staff otologists with at least 5 years of experience in middle ear surgery performed all operations. Surgeons were blind to the results of the MR imaging and independently determined the presence or absence of cholesteatoma in the middle ear. The study was approved by the ethics committee of our hospital (approval No. 68, 2011).
Patients
Sixteen consecutive patients clinically diagnosed with tympanic retraction pockets were recruited and evaluated by an expert otology committee. When a high-risk pocket was scheduled for surgery, the patient was considered a possible candidate and offered an informed consent form. Anonymity was preserved throughout the study.
Imaging Technique
All MRI was performed by using a 1.5T superconducting MR imaging scanner (Magnetom Symphony Maestro Class; Siemens, Erlangen, Germany) with 20-mT/m maximum amplitude gradients. All images were acquired by using a 4-channel circularly ; 14 sections; acquisition time, 2 minutes 33 seconds). Unless dural involvement secondary to middle fossa bone erosion was suspected, all sequences were performed without intravenous injection of gadolinium-based contrast media.
Statistical Analysis
Patients were dichotomically classified as positive or negative for cholesteatoma. Dubious cases were considered as positive, given that a cholesteatoma could not be ruled out. Data were tabulated in a spreadsheet application (Excel for Mac 2011; Microsoft, Bothell, Washington). Diagnostic tests were evaluated by comparing HASTE results against the intraoperative findings. Statistical measures, including sensitivity, specificity, positive predictive value, and negative predictive value, were calculated. Interobserver agreement was calculated by using the coefficient.
RESULTS
Sixteen patients (6 males [37.5%] and 10 females [62.5%]) with ages ranging from 9 to 60 years (mean, 38.8 Ϯ 14.1 years) were included during 2 years (November 2011 to November 2013). There was no difference in the laterality of the disease (8 left-and 8 right-sided).
Intraoperatively, we found cholesteatomas in 10 of 16 retraction pockets (62.5%). Using HASTE resulted in 9 true-positives, zero false-positives, 1 false-negative, and 6 true-negatives (Table) . Radiologically, the size of the cholesteatomas ranged between 3 and 15 mm (mean, 7.4 mm). Calculated statistical measures for HASTE with their respective 95% confidence intervals were as follows: 90% sensitivity (55.5%-99.8%), 100% specificity (54.1%-100%), 100% positive predictive value (66.4%-100%), and 85.7% negative predictive value (42.1%-99.6%). Further analysis included a second neuroradiologist to evaluate the interobserver agreement; the calculated coefficient was 0.875 (0.640 -1.000). There was an additional false-negative in this retrospective analysis, which had been classed as "faintly positive" (a small, weak, hyperintense signal, different from the surrounding tissues) by the first neuroradiologist. Sample images that are representative of different clinical situations are shown in Figs 1-3 .
DISCUSSION
Our results show that HASTE can predict the presence of cholesteatomas in cases of retraction pockets that retain skin or cannot be fully evaluated by direct otomicroscopy and in which the diagnosis is uncertain. The presence of keratin in the cholesteatoma leads to a restrictive pattern with characteristic hyperintensity on DWI, and the use of non-EPI enabled the avoidance of susceptibility artifacts at the skull base, which can be mistaken for or hide a cholesteatoma. 12 Common diagnostic techniques for cholesteatoma, including otomicroscopy and CT, are useful but, in many cases, insufficient. Ganaha et al 13 reported sensitivities, specificities, positive predictive values, and negative predictive values of 77.9%, 92.8%, 97.8%, and 50.0% for otoscopy and 71.1%, 78.5%, 93.3%, and 39.2% for CT, respectively. Although the diagnosis of large cholesteatomas can be adequately accomplished by these methods, detection rates as low as 50%-60% have been described in difficult cases such as residual, recurrent, and congenital cholesteatomas. 13 In addition, the low negative predictive value for CT and otomicroscopy suggests that in questionable cases, like differentiating a small cholesteatoma and a noncholesteatomatous tympanic retraction pocket, further diagnostic tools are needed to rule out the presence of a middle ear cholesteatoma. For these reasons, MR imaging techniques have been proposed for the evaluation of middle ear disease.
Conventional MR Imaging Sequences for the Diagnosis of Cholesteatoma
Cholesteatomas can be difficult to detect and/or appear as nonspecific lesions on standard MR images, 11, 14, 15 but keratin shows a restrictive pattern on DWI. Conventional EP DWI, however, has not yielded sufficiently precise results, especially for cholesteatomas smaller than 5 mm. Jindal et al 11 reported a sensitivity of 83% and a specificity of 82%, while Vercruysse et al 16 reported values of 81% and 100% for primary cholesteatomas and 12.5% and 100% for residual/recurrent cholesteatomas. In EP DWI, the relatively thick sections and presence of air-bone susceptibility artifacts account for these problems.
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The Role of Non-Echo-Planar Diffusion-Weighted MR Imaging in the Diagnosis of Cholesteatomas
Non-EP DWI (including HASTE and PROPELLER sequences) has shown increased sensitivity and specificity, with fewer artifacts and thinner sections, allowing the detection of cholesteatomas measuring 2-3 mm. 12 Several studies have been published since 2006 showing promising results for this technique. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Recently, Li et al 29 summarized these findings in a meta-analysis including 10 articles (342 patients), reporting an overall sensitivity of 94% and specificity of 94%. False-negatives are rare, often caused by motion artifacts or self-evacuating "mural" cholesteatomas, and false-positives are very infrequent. 10, 12, 15, 30 Other advantages to DWI are its short acquisition times (2-5 minutes) and avoidance of intravenous contrast. 22, 31 One of the most studied uses for non-EP DWI in middle ear disease is as an alternative to second-look surgery in canal wall-up mastoidectomies, 32 in which the posterior wall of the external ear canal is preserved. This makes postoperative care easier but impedes direct observation of the mastoidectomy during otomicroscopy, making it impossible to clinically detect residual and recurrent cholesteatomas. 33 Current indications for DWI in cholesteatomas have focused on congenital and residual/recurrent disease, 10 because they can be hidden or difficult to evaluate via otoscopy and postsurgical inflammation may lead to confusion on CT and standard MR imaging. DWI is also helpful in distinguishing differential diagnoses of middle ear masses, especially when combined with delayed postcontrast T1WI. The usefulness of non-EP DWI for detecting patients with incipient disease has been less well-studied. Although excellent previous reports by Pizzini et al, 23 De Foer et al, 26 Profant et al, 27 and Ilıca et al 34 have included primary cholesteatomas among their cases, our research differs in that this was a prospective study that included only retraction pockets with suspicion of cholesteatoma after evaluation by an expert otologic committee. All patients had surgical confirmation, and the data did not include other groups such as recurrent disease. Our aim was to specifically evaluate the diagnostic accuracy of non-EP DWI in difficult cases in which the presence of a middle ear cholesteatoma behind a tympanic retraction pocket was unclear.
The pathogenesis of primary acquired cholesteatomas is complicated and multifactorial, but retraction pockets seem to play an important role 35 ; however, it remains a matter of debate as to whether this pocket can be considered a cholesteatoma. To our knowledge, there are few MR imaging-based articles in the literature assessing the presence of clinically occult cholesteatomas behind tympanic retraction pockets.
Use of Non-EP DW on Tympanic Retraction Pockets
On the basis of our results, we propose that HASTE is a highly sensitive and specific test in the evaluation of high-risk tympanic retraction pockets, where otomicroscopy alone cannot evaluate the extension of skin into the middle ear by direct observation through the external ear canal. CT showing a middle ear mass and/or bone erosion is not specific for cholesteatoma, nor is standard MR imaging. Because DWI gives poor anatomic information, does not evaluate bone erosion, and is not exempt from false-positives and negatives, all of these imaging techniques should be considered as complementary.
In agreement with the literature, we were able to detect cholesteatomas as small as 3 mm. Furthermore, 40% of all HASTEpositive patients in our study had cholesteatomas of Յ5 mm, which could have been missed if EP DWI had been used instead. 12, 24 There was only 1 false-negative in an infected, "wet" cholesteatoma with otorrhea larger than 2-3 mm. We believe that this could be explained by an alteration in the restriction pattern of the suppurated cholesteatoma, but further studies are needed to confirm or refute this hypothesis.
Although the number of subjects is limited because of the specific subset of patients included, this study might broaden the clinical applicability of non-EP DWI, especially in cases in which the diagnosis is uncertain and a more conservative approach is desirable (dangerous tympanic retraction on the better/only hearing ear, high anesthetic risk). Because most cases of cholesteatoma can be adequately diagnosed with otoscopy and CT, judicious use of HASTE MR imaging is important and should be considered only when clinical benefit is expected.
CONCLUSIONS
We have demonstrated that preoperative HASTE MR imaging is highly accurate with regard to detecting the presence or absence of cholesteatoma in tympanic retraction pockets. Early diagnosis of cholesteatomas arising from tympanic retraction pockets could help to better select patients requiring surgery, thus avoiding unnecessary and aggressive procedures.
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